Skip to main content
a b c d e f g h i j k l m n o p q r s t u v w x y z #

Immunology

T Lymphocyte subsets: CD3, CD4, CD8

T Lymphocyte subsets: CD3, CD4, CD8

Age Dependant

Immunophenotyping of blood lymphocytes in childhood reference values for lymphocyte subpopulations. Cooman-Bitter WM, de Groot R et al. J paediatrics 1997,130 pp388-393

T-SPOT.TB ( gamma interferon TB test)

T-SPOT.TB ( gamma interferon TB test)

RESULTS - Positive, Negative, Borderline and Indeterminate results. 

A negative result suggests no active immune response to Mycobacterium Tuberculosis.  A positive results indicates a response to MTB infection, but does not distinguish between active and latent disease. The test cannot be used to exclude active infection, since false-negative results do occur. It should always be interpreted in the context of other clinial and laboratory features.

Due to biological variations, re-testing of borderline (equivocal) results is recommended. Indeterminate results indicate failure of positive or negative controls which may be due to technical or patient-specific factors.  Re-testing recommended.  

Tissue Transglutaminase Antibodies (TTG)

Tissue Transglutaminase Antibodies (TTG)

Negative = <7 U/mL

Weak positive = 7-10 U/mL

Positive = >10 U/mL

Normal result = Negative

TSH Receptor Antibodies

TSH Receptor Antibodies

Negative <0.9 IU/L

Borderline  1.0- 1.4 IU/L

Positive  >1.5 IU/L

Vedolizumab Drug level

Vedolizumab Drug level

37.1 mg/L at week 6
18.4 mg /L at week 14
12.7 mg/L during maintenance treatment.

Vedolizumab Drug level

Vedolizumab Drug level

37.1 mg/L at week 6
18.4 mg /L at week 14
12.7 mg/L during maintenance treatment.

<<  1 2 3 4 [5